CD4 Therapeutics

CD4 Therapeutics

Pre-clinical
Munich, GermanyFounded 2018cd4therapeutics.com

CD4 Therapeutics GmbH is a cutting-edge biopharmaceutical company founded in 2024 by a team of seasoned industry experts with over 30 years of experience in drug development, clinical research and successfully scaling biotech ventures. Our company is driven by the vision to transform patient care by developing groundbreaking therapies that address significant unmet medical needs in autoimmune and inflammatory diseases.

Founded
2018
Focus
Cell & Gene Therapy

About

CD4 Therapeutics GmbH is a cutting-edge biopharmaceutical company founded in 2024 by a team of seasoned industry experts with over 30 years of experience in drug development, clinical research and successfully scaling biotech ventures. Our company is driven by the vision to transform patient care by developing groundbreaking therapies that address significant unmet medical needs in autoimmune and inflammatory diseases.

Funding History

2

Total raised: $15M

Series A$12MAndera PartnersMar 15, 2022
Seed$3MHigh-Tech GründerfondsSep 15, 2020

Company Info

TypePrivate
Founded2018
LocationMunich, Germany
StagePre-clinical
SIMILAR COMPANIES
300Microns
300Microns
Pre-clinical · Munich
BetaSense
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Mireca Medicines
Pre-clinical · Munich
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile